Cargando…

A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease

INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are...

Descripción completa

Detalles Bibliográficos
Autores principales: Rummel, Christian, Aschwanden, Fabian, McKinley, Richard, Wagner, Franca, Salmen, Anke, Chan, Andrew, Wiest, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787548/
https://www.ncbi.nlm.nih.gov/pubmed/29416523
http://dx.doi.org/10.3389/fneur.2017.00727
_version_ 1783295954479218688
author Rummel, Christian
Aschwanden, Fabian
McKinley, Richard
Wagner, Franca
Salmen, Anke
Chan, Andrew
Wiest, Roland
author_facet Rummel, Christian
Aschwanden, Fabian
McKinley, Richard
Wagner, Franca
Salmen, Anke
Chan, Andrew
Wiest, Roland
author_sort Rummel, Christian
collection PubMed
description INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are already in clinical use; however, most of these methods have omitted region-based analysis. Here, we suggest a fully automatic analysis pipeline based on the free software packages FSL and FreeSurfer. MATERIALS AND METHODS: Fifty-five T1-weighted magnetic resonance imaging (MRI) datasets of five patients with confirmed relapsing–remitting MS and mild to moderate disability were longitudinally analyzed compared to a morphometric reference database of 323 healthy controls (HCs). After lesion filling, the volumes of brain segmentations and morphometric parameters of cortical parcellations were automatically screened for global and regional abnormalities. Error margins and artifact probabilities of regional morphometric parameters were estimated. Linear models were fitted to the series of follow-up MRIs and checked for consistency with cross-sectional aging in HCs. RESULTS: As compared to leave-one-out cross-validation in a subset of the control dataset, anomaly detection rates were highly elevated in MRIs of two patients. We detected progressive volume changes that were stronger than expected compared to normal aging in 4/5 patients. In individual patients, we also identified stronger than expected regional decreases of subcortical gray matter, of cortical thickness, and areas of reducing gray–white contrast over time. CONCLUSION: Statistical comparison with a large normative database may provide complementary and rater independent quantitative information about regional morphological changes related to disease progression or drug-related disease modification in individual patients. Regional volume loss may also be detected in clinically stable patients.
format Online
Article
Text
id pubmed-5787548
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57875482018-02-07 A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease Rummel, Christian Aschwanden, Fabian McKinley, Richard Wagner, Franca Salmen, Anke Chan, Andrew Wiest, Roland Front Neurol Neuroscience INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are already in clinical use; however, most of these methods have omitted region-based analysis. Here, we suggest a fully automatic analysis pipeline based on the free software packages FSL and FreeSurfer. MATERIALS AND METHODS: Fifty-five T1-weighted magnetic resonance imaging (MRI) datasets of five patients with confirmed relapsing–remitting MS and mild to moderate disability were longitudinally analyzed compared to a morphometric reference database of 323 healthy controls (HCs). After lesion filling, the volumes of brain segmentations and morphometric parameters of cortical parcellations were automatically screened for global and regional abnormalities. Error margins and artifact probabilities of regional morphometric parameters were estimated. Linear models were fitted to the series of follow-up MRIs and checked for consistency with cross-sectional aging in HCs. RESULTS: As compared to leave-one-out cross-validation in a subset of the control dataset, anomaly detection rates were highly elevated in MRIs of two patients. We detected progressive volume changes that were stronger than expected compared to normal aging in 4/5 patients. In individual patients, we also identified stronger than expected regional decreases of subcortical gray matter, of cortical thickness, and areas of reducing gray–white contrast over time. CONCLUSION: Statistical comparison with a large normative database may provide complementary and rater independent quantitative information about regional morphological changes related to disease progression or drug-related disease modification in individual patients. Regional volume loss may also be detected in clinically stable patients. Frontiers Media S.A. 2018-01-24 /pmc/articles/PMC5787548/ /pubmed/29416523 http://dx.doi.org/10.3389/fneur.2017.00727 Text en Copyright © 2018 Rummel, Aschwanden, McKinley, Wagner, Salmen, Chan and Wiest. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Rummel, Christian
Aschwanden, Fabian
McKinley, Richard
Wagner, Franca
Salmen, Anke
Chan, Andrew
Wiest, Roland
A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title_full A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title_fullStr A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title_full_unstemmed A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title_short A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
title_sort fully automated pipeline for normative atrophy in patients with neurodegenerative disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787548/
https://www.ncbi.nlm.nih.gov/pubmed/29416523
http://dx.doi.org/10.3389/fneur.2017.00727
work_keys_str_mv AT rummelchristian afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT aschwandenfabian afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT mckinleyrichard afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT wagnerfranca afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT salmenanke afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT chanandrew afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT wiestroland afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT rummelchristian fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT aschwandenfabian fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT mckinleyrichard fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT wagnerfranca fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT salmenanke fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT chanandrew fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease
AT wiestroland fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease